Cosmo pharmaceuticals

At Cosmo, we are committed to improve peoples lives by developing products that address unmet medical needs in the fields of gastroenterology, dermatology and healthtech.

Investors

Latest News

25 Jan 2024

Invitation to Cosmo’s Investor Day and Full-Year 2023 Webcast – Zurich, 20 March 2024

Read More
11 Dec 2023
AD HOC

Cosmo Pharmaceuticals and Medtronic forge ahead in AI-driven care

Read More
06 Dec 2023

Cosmo confirms full redemption in cash of €175m Convertible Bonds

Read More

Upcoming Events

13 Mar 2024

J.P. Morgan 14th Annual Pan-European Small/Mid-Cap CEO Conference

Add to Outlook
20 Mar 2024

Full Year Results 2023

Add to Outlook
20 Mar 2024

Investor Day, Zurich

Add to Outlook

Latest presentation

01 Nov 2023
November Investor Presentation

Therapeutic Focus

Cosmo’s therapeutic focus is on the treatment of gastrointestinal diseases (including IBD, colonic infections and colorectal cancer – CRC), increase the effectiveness of endoscopic examinations and to treat persistent skin conditions, like acne, and androgenetic alopecia, that have a long-term physical and emotional impact on lives and self-esteem.

Find out more

Our Mission

To improve people’s lives by developing products that address unmet medical needs in the fields of gastroenterology, dermatology and healthtech.

Find out more

Manufacturing

We provide services related to the production of pharmaceutical products as: assessment of manufacturing processes, technology transfer, evaluation of pharmaceutical product stability, testing and release to the market and drafting of the necessary documentation for pharmaceutical products’ registration.

Find out more